U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 269

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:89979953-89979954
GRCh38:
Chr5:90684136-90684137
ADGRV1E2077fsUsher syndromeLikely pathogenic
(Mar 9, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr10:73405599
GRCh38:
Chr10:71645842
CDH23S384RUsher syndromePathogenic
(Mar 24, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr1:216538381
GRCh38:
Chr1:216365039
USH2AD233fsUsher syndromeLikely pathogenic
(Mar 23, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr1:216538375-216538376
GRCh38:
Chr1:216365033-216365034
USH2AT235fsUsher syndromeLikely pathogenic
(Mar 20, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr1:216258063
GRCh38:
Chr1:216084721
USH2A, USH2A-AS2E1715GUsher syndromeLikely pathogenic
(Feb 24, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr1:216373464-216390728
USH2AUsher syndromeLikely pathogenic
(Feb 22, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr5:89940688
GRCh38:
Chr5:90644871
ADGRV1Usher syndromeLikely pathogenic
(Feb 21, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr9:117266707
GRCh38:
Chr9:114504427
WHRNA126fsUsher syndromeLikely pathogenic
(Feb 20, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr5:90077320
GRCh38:
Chr5:90781503
ADGRV1V4386fsUsher syndromeLikely pathogenic
(Feb 19, 2023)
criteria provided, single submitter
10.
GRCh37:
Chr10:73571349
GRCh38:
Chr10:71811592
CDH23Usher syndromeLikely pathogenic
(Feb 27, 2023)
criteria provided, single submitter
11.
GRCh37:
Chr1:215853573-215853574
GRCh38:
Chr1:215680231-215680232
USH2AN4071fsUsher syndromeLikely pathogenic
(Jan 11, 2023)
criteria provided, single submitter
12.
GRCh37:
Chr1:215963625-216107957
USH2AUsher syndromeLikely pathogenic
(Jan 10, 2023)
criteria provided, single submitter
13.
GRCh37:
Chr17:72916324
GRCh38:
Chr17:74920229
USH1GQ100*, Q203*Usher syndromeLikely pathogenic
(Jan 21, 2023)
criteria provided, single submitter
14.
GRCh37:
Chr5:90078980-90078987
GRCh38:
Chr5:90783163-90783170
ADGRV1L4425fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Dec 27, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr1:216073530-216073531
GRCh38:
Chr1:215900188-215900189
USH2AS2494fsUsher syndromeLikely pathogenic
(Dec 22, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr5:90021387
GRCh38:
Chr5:90725570
ADGRV1E3359*Usher syndromeLikely pathogenic
(Dec 19, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr5:90449059
GRCh38:
Chr5:91153242
ADGRV1A6216fsUsher syndromeLikely pathogenic
(Nov 17, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr5:90136803-90261231
ADGRV1Usher syndromeLikely pathogenic
(Aug 24, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr5:89986685
GRCh38:
Chr5:90690868
ADGRV1R2260*Usher syndromeLikely pathogenic
(Jul 18, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr5:89914999-89968362
ADGRV1Usher syndromeLikely pathogenic
(Jun 1, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr5:90111554
GRCh38:
Chr5:90815737
ADGRV1Usher syndromeLikely pathogenic
(May 23, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr1:215844431-215844437
GRCh38:
Chr1:215671089-215671095
USH2AE4671fsUsher syndromeLikely pathogenic
(Apr 14, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr10:73454017-73468962
CDH23Usher syndromeLikely pathogenic
(Mar 9, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr1:216369929
GRCh38:
Chr1:216196587
USH2A, USH2A-AS1S1406*Usher syndrome, not providedPathogenic
(Nov 21, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr1:215813982-215813983
GRCh38:
Chr1:215640640-215640641
USH2AE4963fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Nov 7, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr1:215990469
GRCh38:
Chr1:215817127
USH2AW3147*Usher syndrome, not providedPathogenic/Likely pathogenic
(Apr 14, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr1:216062129
GRCh38:
Chr1:215888787
USH2AP2621fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Feb 18, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr1:216373234
GRCh38:
Chr1:216199892
USH2A, USH2A-AS1Y1182*Usher syndrome, not providedPathogenic/Likely pathogenic
(Apr 19, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr5:89979676-89979677
GRCh38:
Chr5:90683859-90683860
ADGRV1S1982fsnot provided, Usher syndromePathogenic/Likely pathogenic
(Jun 7, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr1:216462753-216495224
USH2AUsher syndromePathogenic
(Feb 17, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr10:73544680
GRCh38:
Chr10:71784923
CDH23N1845KUsher syndromePathogenic
(Feb 12, 2022)
no assertion criteria provided
32.
GRCh37:
Chr10:73405588-73406374
CDH23Usher syndromenot providedno assertion provided
33.
GRCh37:
Chr17:72916429
GRCh38:
Chr17:74920334
USH1GE168*, E65*Usher syndromeLikely pathogenic
(Jan 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr3:150690306
GRCh38:
Chr3:150972519
CLRN1G64RUsher syndrome, not providedPathogenic/Likely pathogenic
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr5:90150019-90159573
ADGRV1Usher syndromeLikely pathogenic
(Nov 2, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr5:89988604-90077246
ADGRV1Usher syndromeLikely pathogenic
(Nov 15, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr5:89988600
GRCh38:
Chr5:90692783
ADGRV1R2377Qnot specified, not providedConflicting interpretations of pathogenicity
(Jan 11, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr1:216462705
GRCh38:
Chr1:216289363
USH2AA630fsUsher syndromeLikely pathogenic
(Sep 2, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr1:215812582
GRCh38:
Chr1:215639240
USH2AUsher syndromeLikely pathogenic
(Apr 7, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr1:216011333-216040512
USH2AUsher syndromeLikely pathogenic
(Jun 19, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr5:90020647
GRCh38:
Chr5:90724830
ADGRV1not provided, Usher syndrome, Febrile seizures, familial, 4
Pathogenic/Likely pathogenic
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr10:73539134-73539135
GRCh38:
Chr10:71779377-71779378
CDH23H1769fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Mar 7, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr1:216369894
GRCh38:
Chr1:216196552
USH2A-AS1, USH2AUsher syndrome, not provided, Retinitis pigmentosa 39
Pathogenic/Likely pathogenic
(Jan 21, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr10:73565755
GRCh38:
Chr10:71805998
CDH23, LOC111982869not provided, Usher syndromeLikely pathogenic
(Dec 23, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr1:215916678
GRCh38:
Chr1:215743336
USH2Anot providedLikely pathogenic
(Aug 26, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr1:216107957
GRCh38:
Chr1:215934615
USH2AUsher syndrome, not providedLikely pathogenic
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr5:89986637
GRCh38:
Chr5:90690820
ADGRV1V2244IFebrile seizures, familial, 4, Usher syndrome type 2C, Usher syndrome,
not provided
Uncertain significance
(Jun 8, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr14:31353860
GRCh38:
Chr14:30884654
COCH, LOC100506071T244I, T309IUsher syndromeUncertain significance
(Apr 12, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr2:71190407
GRCh38:
Chr2:70963277
ATP6V1B1I342SUsher syndromeUncertain significance
(Apr 12, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr1:216370022
GRCh38:
Chr1:216196680
USH2A, USH2A-AS1S1375LUsher syndrome, not provided, Retinitis pigmentosa 39
Conflicting interpretations of pathogenicity
(Feb 17, 2023)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr1:216500943
GRCh38:
Chr1:216327601
USH2AL280Fnot provided, Usher syndromePathogenic/Likely pathogenic
(Dec 21, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr3:150690308
GRCh38:
Chr3:150972521
CLRN1Y63SUsher syndrome type 3A, Usher syndromePathogenic/Likely pathogenic
(Feb 12, 2022)
no assertion criteria provided
53.
GRCh37:
Chr1:216497696
GRCh38:
Chr1:216324354
USH2AUsher syndrome, not provided, Usher syndrome type 2A,
Retinitis pigmentosa 39
Pathogenic
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr19:48337729
GRCh38:
Chr19:47834472
CRXH10RUsher syndromeUncertain significance
(Jun 5, 2020)
criteria provided, single submitter
55.
GRCh37:
Chr10:73375337
GRCh38:
Chr10:71615580
CDH23L305fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr10:73405588-73406374
CDH23Usher syndromeLikely pathogenic
(Mar 18, 2020)
criteria provided, single submitter
57.
GRCh37:
Chr11:76883787-76883796
GRCh38:
Chr11:77172741-77172750
MYO7AUsher syndrome, not provided, Usher syndrome type 1
Pathogenic/Likely pathogenic
(Jun 18, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr5:90124827
GRCh38:
Chr5:90829010
ADGRV1N5479fsnot provided, Retinal dystrophy, Usher syndrome
Pathogenic/Likely pathogenic
(Feb 20, 2023)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr5:90074268-90074269
GRCh38:
Chr5:90778451-90778452
ADGRV1S4233fsUsher syndrome, Retinal dystrophy, not provided
Pathogenic/Likely pathogenic
(Dec 4, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr1:216270451
GRCh38:
Chr1:216097109
USH2AR1578CRetinitis pigmentosa 39, Usher syndrome, not provided
Pathogenic/Likely pathogenic
(Aug 18, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr1:215963509
GRCh38:
Chr1:215790167
USH2AC3358*Usher syndrome, not providedPathogenic/Likely pathogenic
(Jan 19, 2023)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr10:55591299
GRCh38:
Chr10:53831539
PCDH15not providedUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr1:216138703-216138704
GRCh38:
Chr1:215965361-215965362
USH2AL2359fsUsher syndrome, not providedPathogenic/Likely pathogenic
(Mar 31, 2023)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr15:78403608
GRCh38:
Chr15:78111266
CIB2R33*Usher syndrome, not providedPathogenic
(Feb 19, 2023)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr1:215808017-215808035
GRCh38:
Chr1:215634675-215634693
USH2AT5022fsUsher syndrome, Retinal dystrophy, Usher syndrome type 2,
not provided
Pathogenic/Likely pathogenic
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr1:216420440
GRCh38:
Chr1:216247098
USH2AC766RUsher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39,
Retinal dystrophy, not provided, Retinitis pigmentosa
Pathogenic/Likely pathogenic
(Mar 22, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr1:216258195
Chr1:215848805
GRCh38:
Chr1:216084853
Chr1:215675463
USH2A, USH2A-AS2, USH2AG1671D, T4150ARetinitis pigmentosaLikely pathogenic
(Jun 23, 2019)
no assertion criteria provided
68.
GRCh37:
Chr1:216108091
GRCh38:
Chr1:215934749
USH2AUsher syndromeLikely benign
(May 26, 2020)
reviewed by expert panel
FDA Recognized Database
69.
GRCh37:
Chr10:55955581
GRCh38:
Chr10:54195821
PCDH15N352fs, N389fs, N394fs, N367fsUsher syndromeLikely pathogenic
(Jan 22, 2019)
criteria provided, single submitter
70.
USH2AUsher syndromeLikely pathogenic
(Apr 1, 2018)
no assertion criteria provided
71.
GRCh37:
Chr1:216052410
GRCh38:
Chr1:215879068
USH2AG2752RUsher syndrome, Retinal dystrophy, not provided,
Usher syndrome type 2A
Pathogenic/Likely pathogenic
(Mar 6, 2023)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr5:90086961
GRCh38:
Chr5:90791144
ADGRV1S4772*Usher syndromePathogenic
(Dec 13, 2017)
no assertion criteria provided
73.
GRCh37:
Chr5:140057489-140057494
GRCh38:
Chr5:140677904-140677909
HARS1Usher syndromeUncertain significance
(Aug 28, 2017)
criteria provided, single submitter
74.
GRCh37:
Chr20:34085704
GRCh38:
Chr20:35497875
CEP250R1155*, R523*Cone-rod dystrophy and hearing loss 2Likely pathogenic
(Feb 14, 2020)
criteria provided, single submitter
75.
GRCh37:
Chr10:73550922
GRCh38:
Chr10:71791165
CDH23D2028Anot provided, Usher syndromePathogenic/Likely pathogenic
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:66303767
GRCh38:
Chr17:68307626
ARSGD45YUsher syndrome, type 4, Usher syndromePathogenic
(Aug 3, 2021)
no assertion criteria provided
77.
GRCh37:
Chr1:216166445
GRCh38:
Chr1:215993103
USH2AP2241LRetinitis pigmentosa, Usher syndrome, not provided,
Retinitis pigmentosa 39
Pathogenic/Likely pathogenic
(Nov 5, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr1:216371836
Chr1:215802356
GRCh38:
Chr1:216198494
Chr1:215629014
USH2A, USH2A-AS1, USH2AG1301V, P5107SRetinitis pigmentosa 39Uncertain significance
(Sep 1, 2016)
no assertion criteria provided
79.
GRCh37:
Chr1:216420437
Chr1:216270469
GRCh38:
Chr1:216247095
Chr1:216097127
USH2A, USH2AE767fs, L1572FUsher syndrome type 2APathogenic
(Sep 1, 2016)
no assertion criteria provided
80.
GRCh37:
Chr4:15992840
GRCh38:
Chr4:15991217
PROM1Usher syndromeUncertain significance
(Sep 1, 2016)
no assertion criteria provided
81.
GRCh37:
Chr4:16002235
GRCh38:
Chr4:16000612
PROM1G488*, G479*Usher syndromePathogenic
(Sep 1, 2016)
no assertion criteria provided
82.
GRCh37:
Chr1:216420126
GRCh38:
Chr1:216246784
LOC122152296, USH2AC870*Retinal dystrophy, not provided, Rare genetic deafness,
Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39,
Usher syndrome type 2A
Pathogenic
(Feb 3, 2023)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr11:76885863
GRCh38:
Chr11:77174817
MYO7AR666Q, R655QUsher syndromeUncertain significance
(May 20, 2020)
reviewed by expert panel
FDA Recognized Database
84.
GRCh37:
Chr1:216251604
GRCh38:
Chr1:216078262
USH2A, USH2A-AS2W1800*Usher syndrome, Retinal dystrophy, Usher syndrome type 2A,
Retinitis pigmentosa 39, not provided, Usher syndrome type 2A
Pathogenic
(Nov 8, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr1:215848036
GRCh38:
Chr1:215674694
USH2AL4406PUsher syndromeUncertain significance
(May 20, 2020)
reviewed by expert panel
FDA Recognized Database
86.
GRCh37:
Chr1:215990440
GRCh38:
Chr1:215817098
USH2AQ3157*Retinitis pigmentosa 39, Usher syndrome type 2A, not provided,
Usher syndrome
Pathogenic
(Oct 11, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr1:215901607
GRCh38:
Chr1:215728265
USH2AA3944DUsher syndrome type 2A, Retinitis pigmentosa 39, Usher syndrome
Likely pathogenic
(May 22, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr1:216595636
GRCh38:
Chr1:216422294
USH2AQ15*not provided, Usher syndrome, Usher syndrome type 2A,
Retinitis pigmentosa 39
Pathogenic/Likely pathogenic
(Feb 2, 2023)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr1:216144022
GRCh38:
Chr1:215970680
USH2AL2301SUsher syndrome, Retinal dystrophy, not provided,
Usher syndrome type 2A, Retinitis pigmentosa 39
Conflicting interpretations of pathogenicity
(Jun 3, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr1:216591969
GRCh38:
Chr1:216418627
USH2AS180PRetinitis pigmentosa 39, Usher syndrome type 2A, Usher syndrome,
not provided
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr1:216591855
GRCh38:
Chr1:216418513
USH2ARetinitis pigmentosa 39, Usher syndrome type 2A, Usher syndrome,
not provided
Likely pathogenic
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:215812532
GRCh38:
Chr1:215639190
USH2AT5006MRetinitis pigmentosa 39, Usher syndrome type 2A, not provided,
Usher syndrome, Usher syndrome type 2A, Retinal dystrophy
Pathogenic/Likely pathogenic
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr1:216595439-216595440
GRCh38:
Chr1:216422097-216422098
USH2AQ81fsnot provided, Usher syndrome, Retinitis pigmentosa 39,
Usher syndrome type 2A
Pathogenic
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr1:216496816
GRCh38:
Chr1:216323474
USH2AR517TRetinal dystrophy, not provided, Usher syndrome,
Retinitis pigmentosa 39, Usher syndrome type 2A
Conflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr1:216424240
GRCh38:
Chr1:216250898
USH2Anot provided, Usher syndrome, Retinal dystrophy,
Retinitis pigmentosa 39, Usher syndrome type 2A, Retinitis pigmentosa 39
Pathogenic/Likely pathogenic
(Jan 8, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr1:216348605
GRCh38:
Chr1:216175263
USH2AT1539IUsher syndrome, Retinal dystrophy, Usher syndrome type 2A,
not provided
Conflicting interpretations of pathogenicity
(Apr 12, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr1:216462734
GRCh38:
Chr1:216289392
USH2AC620FUsher syndromeLikely pathogenic
(Feb 25, 2020)
reviewed by expert panel
FDA Recognized Database
98.
GRCh37:
Chr1:215932085
GRCh38:
Chr1:215758743
USH2AY3747*Usher syndromePathogenic
(Sep 17, 2018)
reviewed by expert panel
FDA Recognized Database
99.
GRCh37:
Chr1:215821999
GRCh38:
Chr1:215648657
USH2AP4818LUsher syndrome type 2A, Retinitis pigmentosa 39, Rare genetic deafness,
Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39,
not provided
Pathogenic/Likely pathogenic
(Feb 15, 2023)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr1:216011333-216270555
USH2AUsher syndromePathogenic
(Mar 7, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination